Enanta Pharmaceuticals
NASDAQ: ENTAFounded 1995 · 146 employees on LinkedIn · 2 known investors
Find your way into Enanta Pharmaceuticals
Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
Founders & leadership
JR
Jay R. LulyPresident, Director and Chief Executive Officer
YS
Yat Sun OrChief Scientific Officer
ST
Scott T. RottinghausinChief Medical Officer
MP
Matthew P. KowalskyChief Legal Officer and Corporate Secretary
TL
Tara L. KiefferinChief Product Strategy OfficerTara L. Kieffer holds a B.A. in Molecular Biology from Colgate University and a Ph.D. in Immunology from Johns Hopkins University School of Medicine. She brings extensive pharmaceutical industry experience across drug discovery, development, clinical trials, regulatory affairs, and commercial operations, with particular expertise in infectious disease therapeutics and contributions to hepatitis C treatments.
BL
Brendan LuuinChief Business OfficerHe has over 15 years of experience in business development and drug partnerships, with expertise across oncology, neurology, immunology, virology, and cardiometabolic diseases.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountpublic offeringOct 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Valuation · disclosed
Disclosed events$235.7Mvaluation at IPOMar 2013 · $14.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Enanta Pharmaceuticals went on to found or lead other companies.
In the news
Frequently asked questions
- What does Enanta Pharmaceuticals do?
- Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
- Who are Enanta Pharmaceuticals's investors?
- Enanta Pharmaceuticals's investors include Sofinnova Ventures, AbbVie.